Chiesi USA, Inc.  

Cary,  NC 
United States
https://www.chiesiusa.com/

Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients. We deliver our products and associated services to improve the treatment of patients. We are also dedicated to investing in research and development initiatives that deliver value-added medical solutions in our current therapeutic areas as well as other therapeutic areas where the need exists.

 Products

  • KENGREAL® (cangrelor)
    KENGREAL® (cangrelor) for Injection is a P2Y12 platelet inhibitor indicated as an adjunct to percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor....

  • CLEVIPREX® (clevidipine)
    CLEVIPREX® (clevidipine) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure (BP) when oral therapy is not feasible or not desirable....

  • CUROSURF® (poractant alfa) Intratracheal Suspension
    CUROSURF® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS....

Categories

Product/Company Category
  • Specialty Pharmacy
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Appointment Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined